opiate dependence
Information
- Disease name
- opiate dependence
- Disease ID
- DOID:2559
- Description
- "A drug dependence that involves the continued use of opiate drugs despite despite problems related to use of the substance." [url:http\://en.wikipedia.org/wiki/Opiate_dependency]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01863251 | Completed | Phase 2 | Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia | May 2013 | September 2014 |
| NCT00129298 | Completed | Phase 2 | Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 | December 2004 | April 2007 |
| NCT00130819 | Completed | Phase 2 | Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants | November 2005 | April 2009 |
| NCT00147784 | Completed | Phase 3 | HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. | March 2006 | January 2008 |
| NCT02602795 | Completed | N/A | Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence | December 2015 | June 2018 |
| NCT02617628 | Completed | Phase 2/Phase 3 | Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone | January 1, 2016 | December 31, 2018 |
| NCT02801357 | Completed | Phase 1 | Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction | June 2016 | August 2016 |
| NCT03015597 | Completed | N/A | Pilot Study of Contingency Management for Smoking Cessation | October 2016 | September 2017 |
| NCT03036917 | Completed | Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain | January 1, 2018 | May 3, 2019 | |
| NCT03235154 | Completed | Phase 4 | A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic | October 11, 2017 | September 26, 2019 |
| NCT03527485 | Completed | N/A | Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET | January 1, 2019 | March 28, 2023 |
| NCT03635346 | Completed | Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD | June 3, 2016 | March 10, 2018 | |
| NCT03662529 | Completed | N/A | Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting | June 5, 2017 | February 1, 2018 |
| NCT03681769 | Completed | Early Phase 1 | Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent | February 22, 2019 | March 19, 2021 |
| NCT03718065 | Completed | Phase 2 | Impact of Lofexidine on Stress, Craving and Opioid Use | June 26, 2019 | January 30, 2024 |
| NCT03769025 | Completed | Phase 1/Phase 2 | Remote Observed Dosing of Suboxone to Improve Clinical Practice | April 1, 2019 | July 1, 2022 |
| NCT03971097 | Completed | N/A | The Effect of Self-Forgiveness on Self-Stigma in Addiction. | August 1, 2019 | December 31, 2019 |
| NCT04156802 | Completed | N/A | Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain | June 15, 2020 | July 6, 2022 |
| NCT00170339 | Completed | Bone Density and Serum Testosterone in Male Methadone Maintained Patients | April 2005 | April 2007 | |
| NCT00218621 | Completed | The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1 | September 2005 | February 2009 | |
| NCT00227357 | Completed | The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration | July 2005 | December 2008 | |
| NCT00241917 | Completed | N/A | A Video-Based HCV Curriculum for Drug Users | November 2005 | May 2007 |
| NCT00241943 | Completed | N/A | A Video-Based HCV Curriculum for Active Injection Drug Users | November 2005 | August 2007 |
| NCT00300794 | Completed | Phase 4 | Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia | February 2003 | June 2006 |
| NCT00316277 | Completed | Phase 3 | Prescription Opioid Addiction Treatment Study (POATS) | May 2006 | January 2013 |
| NCT00332228 | Completed | Phase 2 | Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence | June 2002 | December 2007 |
| NCT00367874 | Completed | Phase 4 | Treatment of Polydrug-Using Opiate Dependents During Withdrawal | February 2003 | November 2003 |
| NCT00383045 | Completed | Phase 2 | HIV Risk Reduction and Drug Abuse Treatment in Malaysia | April 2003 | August 2007 |
| NCT00406484 | Completed | Phase 2 | Brief Introductory Therapy for Opioid Dependence | September 2004 | September 2010 |
| NCT00439036 | Completed | Phase 1 | Acceptance Therapy During Methadone Detoxification | July 2006 | December 2012 |
| NCT00475878 | Completed | Phase 3 | SSRI and Buprenorphine | December 2006 | September 2009 |
| NCT00521157 | Completed | Phase 2/Phase 3 | Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction | January 2006 | December 2008 |
| NCT00539123 | Completed | N/A | Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia | September 2007 | August 2012 |
| NCT00548275 | Completed | Phase 2 | Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence | July 2006 | June 2011 |
| NCT00555425 | Completed | Phase 4 | Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence | July 2008 | May 2013 |
| NCT00566969 | Completed | N/A | Cocaine Withdrawal and Pharmacotherapy Response | September 2007 | January 2013 |
| NCT00577408 | Completed | Phase 3 | Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone | September 2007 | August 2011 |
| NCT00580827 | Completed | N/A | Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers | September 2003 | |
| NCT00595764 | Completed | Phase 4 | Counseling for Primary Care Office-based Buprenorphine | August 2005 | February 2011 |
| NCT00604188 | Completed | Phase 4 | A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) | February 22, 2008 | December 10, 2009 |
| NCT00605033 | Completed | Phase 4 | A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) | March 2008 | May 2009 |
| NCT00622596 | Completed | N/A | Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance | October 2003 | September 2008 |
| NCT00633243 | Completed | N/A | Effective Treatment of Hepatitis C in Substance Users | April 2007 | September 2011 |
| NCT00634803 | Completed | Phase 1/Phase 2 | Clinical Trial of Integrated Treatment for Pain and Opioid Dependence | September 2009 | August 2015 |
| NCT00678418 | Completed | Phase 3 | ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence | June 2008 | November 2010 |
| NCT00684073 | Completed | Phase 4 | Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) | July 2007 | December 2007 |
| NCT00684775 | Completed | Phase 2 | Employment-Based Depot Naltrexone Clinical Trial II | May 2008 | April 30, 2010 |
| NCT00684788 | Completed | Phase 2 | Employment-Based Depot Naltrexone Clinical Trial | May 2006 | May 3, 2009 |
| NCT00712036 | Completed | N/A | Entry Into Comprehensive Methadone Treatment Via Interim Maintenance | June 2008 | January 2011 |
| NCT00723697 | Completed | Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) | May 2007 | February 2010 | |
| NCT00723749 | Completed | Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603) | March 2008 | December 2010 | |
| NCT00725608 | Completed | Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) | May 2008 | April 2011 | |
| NCT00757744 | Completed | Phase 3 | Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China | September 2007 | September 2010 |
| NCT00834080 | Completed | Phase 3 | ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals | March 2009 | May 2012 |
| NCT00842036 | Completed | Phase 2 | CRAFT Behavior Therapy: Treatment Entry Component | January 2006 | December 2009 |
| NCT00901875 | Completed | Phase 4 | Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan | March 2009 | January 2010 |
| NCT00987961 | Completed | Phase 3 | Linking Hospitalized Injection Drug Users to Buprenorphine | September 2009 | September 2015 |
| NCT01180647 | Completed | Phase 3 | Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail | May 2010 | July 2013 |
| NCT01182402 | Completed | N/A | Electronic Compliance Monitoring in Opioid Substitution Treatment | September 2010 | February 2011 |
| NCT01218984 | Completed | Phase 2 | ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids | March 2002 | May 2003 |
| NCT01334580 | Completed | Phase 1 | Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment | April 2011 | September 2014 |
| NCT01376570 | Completed | N/A | Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment | June 2012 | August 10, 2017 |
| NCT01389167 | Completed | Phase 3 | Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia | September 2011 | May 2017 |
| NCT01389180 | Completed | Phase 3 | Behavioral Drug and HIV Risk Reduction Counseling With MMT in China | December 2010 | June 2016 |
| NCT01393392 | Completed | Phase 1 | Developing a Smoking Cessation Intervention for Methadone Maintained Smokers | October 2011 | May 2014 |
| NCT01416584 | Completed | N/A | A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment | October 2008 | April 2014 |
| NCT01442493 | Completed | N/A | Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment | September 2011 | August 2015 |
| NCT01512433 | Completed | N/A | The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts | August 2011 | January 2013 |
| NCT01570699 | Completed | Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients | December 2012 | June 2016 | |
| NCT01690546 | Completed | Phase 2 | Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence | September 2012 | February 2015 |
| NCT01779973 | Completed | N/A | Remote Observed Dosing to Increase Suboxone Compliance | February 2013 | September 2013 |
| NCT01848054 | Completed | Phase 3 | Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence | June 2013 | January 2014 |
| NCT00007527 | Completed | Phase 4 | Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice | August 1999 | January 2002 |
| NCT01882361 | Completed | Phase 2/Phase 3 | Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone | June 2013 | July 31, 2020 |
| NCT01913418 | Completed | Phase 2 | Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance | July 2013 | March 2014 |
| NCT02477267 | Completed | Phase 1 | Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers | June 2015 | July 2015 |
| NCT03804619 | Not yet recruiting | N/A | Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder | June 1, 2024 | December 1, 2025 |
| NCT05995873 | Recruiting | N/A | A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders. | January 22, 2024 | August 30, 2024 |
| NCT00439049 | Recruiting | Substance Abuse Pre-Treatment Screening Study | October 2005 | June 2026 | |
| NCT00156936 | Terminated | Phase 3 | ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) | August 2004 | January 2007 |
| NCT01802515 | Terminated | N/A | A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment | December 2012 | March 2014 |
| NCT00218036 | Terminated | Phase 2 | Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8 | July 2006 | February 2010 |
| NCT03538444 | Terminated | N/A | Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder | September 28, 2018 | May 1, 2020 |
| NCT02894476 | Unknown status | Substance Dependence Satisfaction With Care and Quality Of Life | April 2014 | March 2018 | |
| NCT00609089 | Unknown status | Phase 1/Phase 2 | Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction | March 2008 | June 2013 |
| NCT02052258 | Unknown status | Phase 1 | Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence | January 2013 | |
| NCT00241930 | Unknown status | Phase 4 | Integrating Buprenorphine Into HIV Treatment | September 2005 | February 2009 |
| NCT01183130 | Withdrawn | N/A | Compliance Monitoring in Real Time During Opioid Substitution Treatment | August 2011 | April 2012 |
| NCT01160432 | Withdrawn | N/A | Naloxone Methadone Combination (NAMEKO) | May 2013 | July 2013 |
| NCT00398008 | Withdrawn | Phase 2 | HIV Risk Reduction and Drug Abuse Treatment in Iran | October 2004 | December 2008 |
- Disase is a (Disease Ontology)
- DOID:9974
- Cross Reference ID (Disease Ontology)
- ICD10CM:F11.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:304.00
- Cross Reference ID (Disease Ontology)
- MESH:D009293
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:75544000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0524662
- Exact Synonym (Disease Ontology)
- Opioid type dependence